Balazs B, Toth Z, Nagy F, Kovacs R, Toth H, Nagy J
Antibiotics (Basel). 2021; 10(2).
PMID: 33572723
PMC: 7911629.
DOI: 10.3390/antibiotics10020127.
Aris P, Boroumand M, Douraghi M
BMC Microbiol. 2019; 19(1):221.
PMID: 31533627
PMC: 6751817.
DOI: 10.1186/s12866-019-1592-6.
Yoon E, Goussard S, Touchon M, Krizova L, Cerqueira G, Murphy C
mBio. 2014; 5(5):e01972-14.
PMID: 25336457
PMC: 4212838.
DOI: 10.1128/mBio.01972-14.
Kramer J, Matsumura I
PLoS One. 2013; 8(10):e76687.
PMID: 24204655
PMC: 3800079.
DOI: 10.1371/journal.pone.0076687.
Dally S, Lemuth K, Kaase M, Rupp S, Knabbe C, Weile J
Antimicrob Agents Chemother. 2013; 57(10):4761-8.
PMID: 23856783
PMC: 3811405.
DOI: 10.1128/AAC.00863-13.
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Adams-Haduch J, Paterson D, Sidjabat H, Pasculle A, Potoski B, Muto C
Antimicrob Agents Chemother. 2008; 52(11):3837-43.
PMID: 18725452
PMC: 2573138.
DOI: 10.1128/AAC.00570-08.
Acinetobacter baumannii: emergence of a successful pathogen.
Peleg A, Seifert H, Paterson D
Clin Microbiol Rev. 2008; 21(3):538-82.
PMID: 18625687
PMC: 2493088.
DOI: 10.1128/CMR.00058-07.
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
Scheetz M, Qi C, Warren J, Postelnick M, Zembower T, Obias A
Antimicrob Agents Chemother. 2007; 51(5):1621-6.
PMID: 17307973
PMC: 1855572.
DOI: 10.1128/AAC.01099-06.
Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.
Swenson J, Killgore G, Tenover F
J Clin Microbiol. 2004; 42(11):5102-8.
PMID: 15528702
PMC: 525209.
DOI: 10.1128/JCM.42.11.5102-5108.2004.
Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance.
Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M
J Clin Microbiol. 2004; 42(3):946-53.
PMID: 15004037
PMC: 356829.
DOI: 10.1128/JCM.42.3.946-953.2004.
Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000.
Houang E, Chu Y, Lo W, Chu K, Cheng A
Antimicrob Agents Chemother. 2003; 47(4):1382-90.
PMID: 12654674
PMC: 152494.
DOI: 10.1128/AAC.47.4.1382-1390.2003.
Characteristics of clinical Acinetobacter spp. strains.
Hostacka A, Klokocnikova L
Folia Microbiol (Praha). 2002; 47(5):579-82.
PMID: 12503407
DOI: 10.1007/BF02818801.
Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.
Lopez-Otsoa F, Gallego L, Towner K, Tysall L, Woodford N, Livermore D
J Clin Microbiol. 2002; 40(12):4741-3.
PMID: 12454183
PMC: 154648.
DOI: 10.1128/JCM.40.12.4741-4743.2002.
Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides.
Pantophlet R, Severin J, Nemec A, Brade L, Dijkshoorn L, Brade H
Clin Diagn Lab Immunol. 2002; 9(1):60-5.
PMID: 11777830
PMC: 119878.
DOI: 10.1128/cdli.9.1.60-65.2002.
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.
Corbella X, Montero A, Pujol M, Dominguez M, Ayats J, Argerich M
J Clin Microbiol. 2000; 38(11):4086-95.
PMID: 11060073
PMC: 87546.
DOI: 10.1128/JCM.38.11.4086-4095.2000.
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.
Brisse S, Milatovic D, Fluit A, Kusters K, Toelstra A, Verhoef J
J Clin Microbiol. 2000; 38(10):3636-45.
PMID: 11015376
PMC: 87449.
DOI: 10.1128/JCM.38.10.3636-3645.2000.
Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.
Heinemann B, Wisplinghoff H, Edmond M, Seifert H
Antimicrob Agents Chemother. 2000; 44(8):2211-3.
PMID: 10898706
PMC: 90044.
DOI: 10.1128/AAC.44.8.2211-2213.2000.
Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.
Takahashi A, Yomoda S, Kobayashi I, Okubo T, Tsunoda M, Iyobe S
J Clin Microbiol. 2000; 38(2):526-9.
PMID: 10655339
PMC: 86139.
DOI: 10.1128/JCM.38.2.526-529.2000.